Neuropeptides modulate RANKL and OPG expression in human periodontal ligament cells

Orthodontic Waves

Volumn 66, Issue 2, 2007, Pages 33-40

  Nakao, Kayoko ^a   Goto, Tetsuya ^a   Gunjigake, Kaori ^a   Konoo, Tetsuro ^a   Kobayashi, Shigeru ^a   Yamaguchi, Kazunori ^a  

^a KYUSHU DENTAL COLLEGE   (Japan)

Author keywords

CGRP; OPG; Periodontal ligament cell; RANKL; Substance P

Indexed keywords

EID: 34250729858     PISSN: 13440241     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.odw.2007.03.004     Document Type: Article

References (41)

1. Olgart L., Gazelius B., Brodin E., and Nilsson G. Release of substance P-like immunoreactivity from the dental pulp. Acta Physiol Scand 101 (1977) 510-512
2. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiol Rev 73 (1993) 229-308
3. Lembeck F., and Holzer P. Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 310 (1979) 175-183
4. Mori T., Ogata T., Okumura H., Shibata T., Nakamura Y., and Kataoka K. Substance P regulates the function of rabbit cultured osteoclast; increase of intracellular free calcium concentration and enhancement of bone resorption. Biochem Biophys Res Commun 262 (1999) 418-422
5. Lerner U.H. Neuropeptidergic regulation of bone resorption and bone formation. J Musculoskelet Neuronal Interact 2 (2002) 440-447
6. Azuma H., Kido J., Ikedo D., Kataoka M., and Nagata T. Substance P enhances the inhibition of osteoblastic cell differentiation induced by lipopolysaccharide from Porphyromonas gingivalis. J Periodontol 75 (2004) 974-981
7. Maggi C.A., Patacchini R., Rovero P., and Giachetti A. Tachykinin receptors and tachykinin receptor antagonists. J Auton Pharmacol 13 (1993) 23-93
8. Snijdelaar D.G., Dirksen R., Slappendel R., and Crul B.J. Substance P. Eur J Pain 4 (2000) 121-135
9. Davidovitch Z., Nicolay O.F., Ngan P.W., and Shanfeld J.L. Neurotransmitters, cytokines, and the control of alveolar bone remodeling in orthodontics. Dent Clin North Am 32 (1988) 411-435
10. Goto T., Yamaza T., Kido M.A., and Tanaka T. Substance P activates osteoclast formation and osteoclastic bone resorption through the neurokinin-1 receptor. Acta Histochem Cytochem 34 (2001) 31-38
11. Goto T., Nakao K., Gunjigake K.K., Kido M.A., Kobayashi S., and Tanaka T. Substance P stimulates late-stage rat osteoblastic bone formation through neurokinin-1 receptors. Neuropeptides 41 (2007) 25-31
12. Gunjigake K.K., Goto T., Nakao K., Konoo T., Kobayashi S., and Yamaguchi K. Correlation between the appearance of neuropeptides in the rat trigeminal ganglion and reinnervation of the healing root socket after tooth extraction. Acta Histochem Cytochem 39 (2006) 61-69
13. Wakisaka S., Nishikawa S., Ichikawa H., Matsuo S., Takano Y., and Akai M. The distribution and origin of substance P-like immunoreactivity in the rat molar pulp and periodontal tissues. Arch Oral Biol 30 (1985) 813-818
14. Vandevska-Radunovic V., Kvinnsland S., and Kvinnsland I.H. Effect of experimental tooth movement on nerve fibres immunoreactive to calcitonin gene-related peptide, protein gene product 9.5, and blood vessel density and distribution in rats. Eur J Orthod 19 (1997) 517-529
15. Heyeraas K.J., Kvinnsland I., Byers M.R., and Jacobsen E.B. Nerve fibers immunoreactive to protein gene product 9.5, calcitonin gene-related peptide, substance P, and neuropeptide Y in the dental pulp, periodontal ligament, and gingiva in cats. Acta Odontol Scand 51 (1993) 207-221
16. Jacobsen E.B., Fristad I., and Heyeraas K.J. Nerve fibers immunoreactive to calcitonin gene-related peptide, substance P, neuropeptide Y, and dopamine beta-hydroxylase in innervated and denervated oral tissues in ferrets. Acta Odontol Scand 56 (1998) 220-228
17. Norevall L.I., Forsgren S., and Matsson L. Expression of neuropeptides (CGRP, substance P) during and after orthodontic tooth movement in the rat. Eur J Orthod 17 (1995) 311-325
18. Nicolay O.F., Davidovitch Z., Shanfeld J.L., and Alley K. Substance P immunoreactivity in periodontal tissues during orthodontic tooth movement. Bone Miner 11 (1990) 19-29
19. Zaidi M., Fuller K., Bevis P.J., GainesDas R.E., Chambers T.J., and MacIntyre I. Calcitonin gene-related peptide inhibits osteoclastic bone resorption: a comparative study. Calcif Tissue Int 40 (1987) 149-154
20. Ishizuka K., Hirukawa K., Nakamura H., and Togari A. Inhibitory effect of CGRP on osteoclast formation by mouse bone marrow cells treated with isoproterenol. Neurosci Lett 379 (2005) 47-51
21. Cornish J., Callon K.E., Bava U., Kamona S.A., Cooper G.J., and Reid I.R. Effects of calcitonin, amylin, and calcitonin gene-related peptide on osteoclast development. Bone 29 (2001) 162-168
22. Middleton J., Jones M., and Wilson A. The role of the periodontal ligament in bone modeling: the initial development of a time-dependent finite element model. Am J Orthod Dentofacial Orthop 109 (1996) 155-162
23. Hofbauer L.C., Khosla S., Dunstan C.R., Lacey D.L., Boyle W.J., and Riggs B.L. The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption. J Bone Miner Res 15 (2000) 2-12
24. Kanzaki H., Chiba M., Shimizu Y., and Mitani H. Dual regulation of osteoclast differentiation by periodontal ligament cells through RANKL stimulation and OPG inhibition. J Dent Res 80 (2001) 887-891
25. Hasegawa T., Yoshimura Y., Kikuiri T., Yawaka Y., Takeyama S., Matsumoto A., et al. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodontal Res 37 (2002) 405-411
26. Zhang D., Yang Y.Q., Li X.T., and Fu M.K. The expression of osteoprotegerin and the receptor activator of nuclear factor kappa B ligand in human periodontal ligament cells cultured with and without 1alpha,25-dihydroxyvitamin D3. Arch Oral Biol 49 (2004) 71-76
27. Yamaguchi M., Aihara N., Kojima T., and Kasai K. RANKL increase in compressed periodontal ligament cells from root resorption. J Dent Res 85 (2006) 751-756
28. Opas M. Expression of the differentiated phenotype by epithelial cells in vitro is regulated by both biochemistry and mechanics of the substratum. Dev Biol 131 (1989) 281-293
29. Matayoshi T., Goto T., Fukuhara E., Takano H., Kobayashi S., and Takahashi T. Neuropeptide substance P stimulates the formation of osteoclasts via synovial fibroblastic cells. Biochem Biophys Res Commun 327 (2005) 756-764
30. Goto T., Yamaza T., Kido M.A., and Tanaka T. Light- and electron-microscopic study of the distribution of axons containing substance P and the localization of neurokinin-1 receptor in bone. Cell Tissue Res 293 (1998) 87-93
31. Goto T., Kido M.A., Yamaza T., and Tanaka T. Substance P and substance P receptors in bone and gingival tissues. Med Electron Microsc 34 (2001) 77-85
32. Fristad I., Vandevska-Radunovic V., Fjeld K., Wimalawansa S.J., and Hals Kvinnsland I. NK1, NK2, NK3 and CGRP1 receptors identified in rat oral soft tissues, and in bone and dental hard tissue cells. Cell Tissue Res 311 (2003) 383-391
33. Vandevska-Radunovic V., Fristad I., Wimalawansa S.J., and Hals Kvinnsland I. CGRP1 and NK1 receptors in postnatal, developing rat dental tissue. Eur J Oral Sci 111 (2003) 497-502
34. Goga Y., Chiba M., Shimizu Y., and Mitani H. Compressive force induces osteoblast apoptosis via caspase-8. J Dent Res 85 (2006) 240-244
35. Ziche M., Morbidelli L., Pacini M., Dolara P., and Maggi C.A. NK1-receptors mediate the proliferative response of human fibroblasts to tachykinins. Br J Pharmacol 100 (1990) 11-14
36. Harrison N.K., Dawes K.E., Kwon O.J., Barnes P.J., Laurent G.J., and Chung K.F. Effects of neuropeptides on human lung fibroblast proliferation and chemotaxis. Am J Physiol 268 (1995) L278-L283
37. Kanzaki H., Chiba M., Shimizu Y., and Mitani H. Periodontal ligament cells under mechanical stress induce osteoclastogenesis by receptor activator of nuclear factor kappaB ligand up-regulation via prostaglandin E2 synthesis. J Bone Miner Res 17 (2002) 210-220
38. Kojima T., Yamaguchi M., and Kasai K. Substance P stimulates release of RANKL via COX-2 expression in human dental pulp cells. Inflamm Res 55 (2006) 78-84
39. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 (1997) 309-319
40. Tsuji K., Uno K., Zhang G.X., and Tamura M. Periodontal ligament cells under intermittent tensile stress regulate mRNA expression of osteoprotegerin and tissue inhibitor of matrix metalloprotease-1 and -2. J Bone Miner Metab 22 (2004) 94-103
41. Villa I., Mrak E., Rubinacci A., Ravasi F., and Guidobono F. CGRP inhibits osteoprotegerin production in human osteoblast-like cells via cAMP/PKA-dependent pathway. Am J Physiol Cell Physiol 291 (2006) C529-C537